Complementary Effects of Surgery and Pexidartinib in the Management of Patients with Complex Diffuse-Tenosynovial Giant Cell Tumor

Figure 4

Histology images in the hip post-pexidartinib treatment. The posttreatment specimen was less cellular compared to the pretreatment tissue and demonstrated a relative increased number of foamy histiocytes and significantly decreased number of multinucleated giant cells (H&E 200X).